Publication | Open Access

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)

Injected DnazymeMedicineCancer DiagnosisHead And Neck CancerPhase 1DermatologyNeck OncologyNodular Basal-cell CarcinomaOncologyRadiation OncologyCancer ResearchMolecular OncologySkin Cancer